Browse the full management transaction log of Novo Integrated Sciences, Inc., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Novo Integrated Sciences, Inc. has published 1 insider filings. Market capitalisation: €1,267.8bn. The latest transaction was disclosed on 21 April 2022 — Acquisition. Among the most active insiders: Oliva Robert Letterio. The full history is accessible without an account.